PI31 expression prevents neuronal degeneration in a mouse Parkinson Disease model
Abstract
Age-related neurodegenerative diseases pose a major unmet health need since no effective treatment strategies are currently available. These disorders are defined by the accumulation of abnormal protein aggregates that impair synaptic function and cause progressive neuronal degeneration. Therefore, stimulating protein clearance mechanisms may be neuro-protective. The proteasome regulator PI31 promotes local protein degradation at synapses by mediating fast proteasome transport in neurites, and loss of PI31 function causes neuronal degeneration. Here we show that transgenic expression of PI31 in a mouse Parkinsons Disease model preserves neuronal function and greatly extends animal health and lifespan. These results indicate that targeting the PI31-pathway may have therapeutic value for treating neurodegenerative disorders.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The proteasome regulator PI31 is required for protein homeostasis, synapse maintenance and neuronal survival in mice
Adi Minis, Jose A. Rodriguez, … Hermann Steller·Proceedings of the National Academy of SciencesPeer-reviewed·Nov 21, 2019
- The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease
Maritza Oñate, Alejandra Catenaccio, … Felipe A. Court·Cell Death and DifferentiationPeer-reviewed·Oct 7, 2019
- PI31 is an adaptor protein for proteasome transport in axons and required for synaptic development and function
Kai Liu, Sandra Jones, … Hermann Steller·bioRxiv·Jan 15, 2019
- Targeting neuroinflammation by pharmacologic down-regulation of inflammatory pathways is neuroprotective in protein misfolding disorders.
Sydney J. Risen, Sean W. Boland, … Julie A. Moreno·ACS Chemical NeurosciencePeer-reviewed·Mar 20, 2024
- α-synuclein over expression, NRF2 suppression, and enhanced ferroptosis creates a vicious cycle of neuronal loss in Parkinson's disease
Annadurai Anandhan, W Chen, … D.D. Zhang·bioRxiv·Jul 22, 2022
- Complement and coagulation cascades are potentially involved in dopaminergic neurodegeneration in alpha-synuclein-based mouse models of Parkinson's disease
Shi-Xun Ma, Bo Am Seo, … Han Seok Ko·Journal of Proteome ResearchPeer-reviewed·Jun 1, 2021